This page is free to read, and it stops after 2 rows. Everything we currently hold fits inside that, so nothing is being held back here today. Reading the whole list, and the company page behind every filing, is part of the subscription. So are this filer’s key figures — how many filings and open-market buys they reported, and over which period — the price beside each line, and the measured buy-following figure where there is one. What that costs is on the pricing page.
Filings
2On an award the register reports a price of 0: nothing was paid, and the Quantity column shows the size.
| Company | Transaction | Reported |
|---|---|---|
| Vivoryon Therapeutics N.V.CFO | Awardnothing paidquantity 60,000 | Apr 22, 2026 |
| Vivoryon Therapeutics N.V.CFO (not formally appointed as director within the meaning of Dutch Corporate law) | Awardnothing paidquantity 20,000 | Oct 21, 2025 |